For many years our service at the Timone Hospital has collaborated with researchers including the " Natural Killer Cells and Innate Immunity" team of Eric VIVIER .
As a an internal medicine physician, I am often faced with patients who have conditions that result from immune system dysfunctions. These inflammatory or autoimmune diseases are often rare diseases whose causes and symptoms are misunderstood: lupus, myositis autoimmune diseases, immune deficiencies in adults, systemic fibrosis, etc.
Like Marseille Immunopole, our discipline is positioned at the interface of different medical specialties, but also of fundamental and translational research. For many years our service at the Timone Hospital has collaborated with researchers including the ” Natural Killer Cells and Innate Immunity” team of Eric VIVIER at CIML. Together, we have developed a laboratory at the Conception Hospital specializing in the functional exploration of these lymphocytes and rare lymphocyte populations. We are conducting studies to better understand their involvement in diseases such as Systemic Lupus Erythematosus, Immune Thrombocytopenia Purpura (ITP) or IgG4-related diseases. The laboratory has also developed a routine battery of tests to quantify and qualify the activity of NK cells, T helper cells (Th) and Innate Lymphoid Cells (ILCs), particularly in clinical trials.#clinic
This is the DNA of the cluster to feed local excellence, including, of course, fundamental and applied immunology, and to support the emergence of sector initiatives with strong potential.
HalioDx is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.
We and our patients are resolutely committed to the Marseille Immunopôle; patients no longer wish to be simple "providers of biological samples", but full participants in the research process.
New molecules currently under development at Innate Pharma and in new companies in Marseille reflect the teams' dynamism and local potential.